Patent · US Active

α,β-unsaturated amide compound

US11447471B2 · kind B2 · utility

0Cited by
2References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2018
Grant dateSep 20, 2022
Priority date—
Expiry dateJul 23, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/052
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

An object of the present invention is to provide an α,β-unsaturated amide compound or a pharmaceutically acceptable salt or the like thereof having anticancer activity and the like. The α,β-unsaturated amide compound represented by the following formula (I) or a pharmaceutically acceptable salt or the like thereof has anticancer activity and the like: [wherein, “A” represents optionally substituted heterocyclic diyl,

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.